• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于循环肿瘤细胞培养探索促进肾癌细胞转移和植入的潜在驱动基因突变

Exploring the Potential Driver Gene Mutations That Promote Renal Cancer Cell Metastasis and Implantation Based on Circulating Tumor Cells Culture.

作者信息

Hong Baoan, Zhang Xuezhou, Du Xin, Yang Dazhi, Hu Zhiyuan, Zhang Xiuli, Zhang Ning

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

出版信息

Diagnostics (Basel). 2023 May 25;13(11):1855. doi: 10.3390/diagnostics13111855.

DOI:10.3390/diagnostics13111855
PMID:37296706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10252915/
Abstract

Studies have shown that the circulating tumor cell (CTC) is a necessary condition for the invasion and distant metastasis of renal cell carcimona (RCC). However, few CTCs-related gene mutations have been developed which could promote the metastasis and implantation of RCC. The objective of this study is to explore the potential driver gene mutations that promote RCC metastasis and implantation based on CTCs culture. Fifteen patients with primary mRCC and three healthy subjects were included, and peripheral blood was obtained. After the preparation of synthetic biological scaffolds, peripheral blood CTCs were cultured. Successful cultured CTCs were applied to construct CTCs-derived xenograft (CDX) models, followed by DNA extraction, whole exome sequencing (WES) and bioinformatics analysis. Synthetic biological scaffolds were constructed based on previously applied techniques, and peripheral blood CTCs culture was successfully performed. We then constructed CDX models and performed WES, and explored the potential driver gene mutations that may promote RCC metastasis and implantation. Bioinformatics analysis showed that KAZN and POU6F2 may be closely related to the prognosis of RCC. We successfully performed the culture of peripheral blood CTCs and, on this basis we initially explored the potential driver mutations for the metastasis and implantation of RCC.

摘要

研究表明,循环肿瘤细胞(CTC)是肾细胞癌(RCC)侵袭和远处转移的必要条件。然而,目前很少有与CTC相关的基因突变被发现可促进RCC的转移和植入。本研究的目的是基于CTC培养探索促进RCC转移和植入的潜在驱动基因突变。纳入15例原发性转移性肾细胞癌患者和3名健康受试者,采集外周血。制备合成生物支架后,对外周血CTC进行培养。将成功培养的CTC用于构建源自CTC的异种移植(CDX)模型,随后进行DNA提取、全外显子测序(WES)和生物信息学分析。基于先前应用的技术构建合成生物支架,成功进行了外周血CTC培养。然后我们构建了CDX模型并进行了WES,并探索了可能促进RCC转移和植入的潜在驱动基因突变。生物信息学分析表明,KAZN和POU6F2可能与RCC的预后密切相关。我们成功地进行了外周血CTC的培养,并在此基础上初步探索了RCC转移和植入的潜在驱动突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/fb0dd36ceca3/diagnostics-13-01855-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/d9b87a6887cb/diagnostics-13-01855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/e59c284fbcdd/diagnostics-13-01855-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/cf2610cf7c7f/diagnostics-13-01855-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/482a7b347fe9/diagnostics-13-01855-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/74cbba1434f2/diagnostics-13-01855-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/fb0dd36ceca3/diagnostics-13-01855-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/d9b87a6887cb/diagnostics-13-01855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/e59c284fbcdd/diagnostics-13-01855-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/cf2610cf7c7f/diagnostics-13-01855-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/482a7b347fe9/diagnostics-13-01855-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/74cbba1434f2/diagnostics-13-01855-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b17/10252915/fb0dd36ceca3/diagnostics-13-01855-g006.jpg

相似文献

1
Exploring the Potential Driver Gene Mutations That Promote Renal Cancer Cell Metastasis and Implantation Based on Circulating Tumor Cells Culture.基于循环肿瘤细胞培养探索促进肾癌细胞转移和植入的潜在驱动基因突变
Diagnostics (Basel). 2023 May 25;13(11):1855. doi: 10.3390/diagnostics13111855.
2
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.通过转移性前列腺癌循环肿瘤细胞的全外显子组测序,获得转移性突变内容的一种可及且独特的见解。
Eur Urol Oncol. 2020 Aug;3(4):498-508. doi: 10.1016/j.euo.2018.12.005. Epub 2019 Jan 4.
3
The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.循环肿瘤细胞(CTCs)和 CTC 白细胞簇在肾细胞癌患者中的预后价值。
BMC Cancer. 2021 Jul 17;21(1):826. doi: 10.1186/s12885-021-08463-7.
4
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and in Metastasis.播散循环肿瘤细胞揭示了NFκB、上皮-间质转化(EMT)和转化生长因子β(TGFβ)信号通路在转移中的潜在作用。
Cancers (Basel). 2023 Mar 17;15(6):1831. doi: 10.3390/cancers15061831.
5
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.循环肿瘤细胞在转移性肾细胞癌中的预后作用:一项大型、多中心、前瞻性试验
Oncologist. 2021 Sep;26(9):740-750. doi: 10.1002/onco.13842. Epub 2021 Jun 17.
6
Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.动态变化的不同表型和遗传循环肿瘤细胞作为评估 RCC 预后的生物标志物。
Cancer Biol Ther. 2019;20(4):505-512. doi: 10.1080/15384047.2018.1537576. Epub 2018 Oct 25.
7
Detection of Circulating Tumor Cells in Renal Cell Carcinoma: Disease Stage Correlation and Molecular Characterization.肾细胞癌中循环肿瘤细胞的检测:疾病分期相关性及分子特征
J Clin Med. 2020 May 7;9(5):1372. doi: 10.3390/jcm9051372.
8
Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.肾细胞癌患者中两种循环肿瘤细胞检测系统的比较。
Int Urol Nephrol. 2018 Oct;50(10):1801-1809. doi: 10.1007/s11255-018-1954-2. Epub 2018 Aug 18.
9
Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer.循环肿瘤细胞全外显子测序探索晚期非小细胞肺癌中的铂类药物耐药突变
Front Genet. 2021 Sep 20;12:722078. doi: 10.3389/fgene.2021.722078. eCollection 2021.
10
Prognostic value of circulating tumor cells and immune-inflammatory cells in patients with renal cell carcinoma.肾细胞癌患者循环肿瘤细胞和免疫炎症细胞的预后价值
Urol Oncol. 2022 Apr;40(4):167.e21-167.e32. doi: 10.1016/j.urolonc.2021.12.021. Epub 2022 Feb 23.

引用本文的文献

1
A revolutionary era in advancing precision immuno-oncology; role of circulating tumor cells.推进精准免疫肿瘤学的一个变革性时代;循环肿瘤细胞的作用。
J Liq Biopsy. 2024 Oct 11;6:100169. doi: 10.1016/j.jlb.2024.100169. eCollection 2024 Dec.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma.2022 年更新版的欧洲泌尿外科学会关于辅助免疫检查点抑制剂治疗肾细胞癌的指南。
Eur Urol. 2023 Jan;83(1):10-14. doi: 10.1016/j.eururo.2022.10.010. Epub 2022 Oct 27.
3
Oncogene or tumor suppressor gene: An integrated pan-cancer analysis of .癌基因或抑癌基因:泛癌分析 。
Front Endocrinol (Lausanne). 2022 Aug 17;13:950326. doi: 10.3389/fendo.2022.950326. eCollection 2022.
4
KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data.KAZN 作为卵巢癌的诊断标志物:基于微阵列、mRNA 测序和甲基化数据的综合分析。
BMC Cancer. 2022 Jun 16;22(1):662. doi: 10.1186/s12885-022-09747-2.
5
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南:2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.
6
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.实现全基因组和全外显子组测序中癌症基因突变检测的最佳实践。
Nat Biotechnol. 2021 Sep;39(9):1141-1150. doi: 10.1038/s41587-021-00994-5. Epub 2021 Sep 9.
7
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.前瞻性评估多联液体活检在转移性前列腺癌中针对多种耐药机制的临床结局。
J Clin Oncol. 2021 Sep 10;39(26):2926-2937. doi: 10.1200/JCO.21.00169. Epub 2021 Jul 1.
8
Circulating tumor cell detection methods in renal cell carcinoma: A systematic review.循环肿瘤细胞检测方法在肾细胞癌中的应用:系统评价。
Crit Rev Oncol Hematol. 2021 May;161:103331. doi: 10.1016/j.critrevonc.2021.103331. Epub 2021 Apr 20.
9
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.开发并初步临床试验检测用于透明细胞肾细胞癌患者的多重循环肿瘤细胞检测。
Mol Oncol. 2021 Sep;15(9):2330-2344. doi: 10.1002/1878-0261.12931. Epub 2021 Mar 3.
10
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.循环肿瘤 DNA 在晚期实体瘤中的临床意义和未来方向。
CA Cancer J Clin. 2021 Mar;71(2):176-190. doi: 10.3322/caac.21650. Epub 2020 Nov 9.